The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ
By: Xue Wang, Shuaishuai Huang, Xia Xin, Yu Ren, Guobin Weng and Ping Wang
Authors
Xue Wang
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China
Shuaishuai Huang
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China
Xia Xin
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Yu Ren
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China
Guobin Weng
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China
Ping Wang
Ningbo University, School of Medicine, Ningbo, China
Language: English
Page range: 111 - 119
Accepted on: Aug 18, 2018
Published on: Dec 7, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2018 Xue Wang, Shuaishuai Huang, Xia Xin, Yu Ren, Guobin Weng, Ping Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.